Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9594 posts found.

Patent office shows tougher stance on “evergreening”

March 18, 2009 Research and Development Europe

The rate of patent applications refused in Europe has risen to an all time high, as authorities target "evergreening" of …
News

Getting the most out of your product portfolio

March 17, 2009 Research and Development, Sales and Marketing portfolio, product

Portfolio planning should be a practical process that delivers a programme of work to take you to sunnier shores. All …
Feature

One in five European biotech companies facing bankruptcy

March 17, 2009 Research and Development biotech

Around one in five European biotech companies could go bust by the end of 2009 if new funding doesn't emerge …
News

Blow for Genzyme as FDA finds fault with Allston facility

March 13, 2009 Research and Development, Sales and Marketing FDA, Genzyme

The chances of approval for Genzyme's new Pompe disease drug Lumizyme have diminished dramatically after the US Food and Drug …
News

Working Life: Andrew Clark

March 13, 2009 Research and Development, Sales and Marketing UCB, library

How did you find your way into your current role? On return from a working holiday to New Zealand I …
Feature

Government picks top-level NHS-academic research centres

March 12, 2009 Research and Development Academic

Five establishments have been named by the government as Academic Health Science Centres (AHSCs). The centres – UCL Partners, Cambridge …
News

Obama ends stem cell funding ban

March 10, 2009 Research and Development US, stem cell

President Obama has lifted the US ban on federal funding for new stem cell research, signalling another marked departure in …
News

The evolution of the eCTD

March 10, 2009 Research and Development eCTD, electronic common technical document, reg affairs

Feature

Are biosimilars delivering the goods in the EU?

March 10, 2009 Manufacturing and Production, Research and Development biosimilars

In January, leading pharmaceutical experts attended the 2009 Forum Institute seminar on biosimilars, and the challenges involved in their successful …
News

UK’s Stem Cell Sciences acquired by US company

March 5, 2009 Research and Development Stem cells

US company StemCells Inc is to expand its capabilities in the field with the purchase of UK based Stem Cell …
News

NICE rejects Tyverb despite price offer

March 5, 2009 Research and Development NICE, Tyverb

NICE has rejected GSK's breast cancer drug Tyverb, despite an offer from the company to cut the cost of treatment. …
News

Obama makes ‘downpayment’ on US healthcare reform

March 5, 2009 Research and Development US, healthcare

President Barack Obama has reiterated his aim of bringing universal healthcare to the US and has put a $76.8 billion …
News

Symbicort gains COPD indication

March 4, 2009 Research and Development Symbicort

AstraZeneca's respiratory drug Symbicort can be used to help US patients with chronic obstructive pulmonary disease (COPD). The FDA has …
News

First-in-class cancer treatment Vidaza launched

March 3, 2009 Research and Development Vidaza

Vidaza, an innovative new treatment for a number of hard-to-treat blood cancers, has been launched in the UK by Celgene. …
News

Safety concerns give Raptiva ‘no way back’

March 2, 2009 Research and Development Raptiva, drug safety

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026